Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients
An Open Prospective Randomised Long-Term Effectiveness Study, Comparing Best Medical Practice With or Without Adjunctive VNS Therapy in Patients 16 Years and Older With Pharmaco-resistant Partial Epilepsy
Sponsor: Cyberonics, Inc.
Terminated
Insufficient enrollment
Other terminated trials from Cyberonics, Inc.
More terminations from Cyberonics, Inc.
A PHASE4 clinical study on Epilepsy and Partial Epilepsy, this trial is terminated or withdrawn. The trial is conducted by Cyberonics, Inc. and has accumulated 8 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Feb 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cyberonics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ancona, Italy , Blaricum, Netherlands , Bologna, Italy , Bonn, Germany , Brussels, Belgium , Calgary, Canada , Cambridge, United Kingdom , Enschede, Netherlands , Erlangen, Germany , Fazakerley, United Kingdom and 34 more locations